SynthesisPloS one2013
Development and validation of a risk score predicting substantial weight gain over 5 years in middle-aged European men and women.
Synthesis in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 19 citations in OpenAlex.
- Development and internal validation of a risk score for incident obesity among Peruvian formal workers.Obesity pillars · 2026Article
- Lipidomic Signatures of Changes in Adiposity: A Large Prospective Study of 5849 Adults from the Australian Diabetes, Obesity and Lifestyle Study.Metabolites · 2021Article
- The future burden of obesity in Canada: a modelling study.Canadian journal of public health = Revue canadienne de sante publique · 2019Article
- Using metabolite profiling to construct and validate a metabolite risk score for predicting future weight gain.PloS one · 2019Article
- Development and validation of a population based risk algorithm for obesity: The Obesity Population Risk Tool (OPoRT).PloS one · 2018Article
- Predicting risk of substantial weight gain in German adults-a multi-center cohort approach.European journal of public health · 2017Article
- Erythritol is a pentose-phosphate pathway metabolite and associated with adiposity gain in young adults.Proceedings of the National Academy of Sciences of the United States of America · 2017Article
- Plasma MicroRNA signature predicting weight gain among Mexican-American women.Obesity (Silver Spring, Md.) · 2017Article
- The influence of adjustment for energy misreporting on relations of cake and cookie intake with cardiometabolic disease risk factors.European journal of clinical nutrition · 2016Article
- Changes in body weight and obesity status in German adults: results of seven population-based prospective studies.European journal of clinical nutrition · 2016Article
- Road Traffic and Railway Noise Exposures and Adiposity in Adults: A Cross-Sectional Analysis of the Danish Diet, Cancer, and Health Cohort.Environmental health perspectives · 2016Article
- Predictors of marked weight gain in a population of health care and industrial workers following smoking cessation.BMC public health · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
35 authors at 20 institutions in 10 countries.
Funding
Abstract
backgroundIdentifying individuals at high risk of excess weight gain may help targeting prevention efforts at those at risk of various metabolic diseases associated with weight gain. Our aim was to develop a risk score to identify these individuals and validate it in an external population.
methodsWe used lifestyle and nutritional data from 53°758 individuals followed for a median of 5.4 years from six centers of the European Prospective Investigation into Cancer and Nutrition (EPIC) to develop a risk score to predict substantial weight gain (SWG) for the next 5 years (derivation sample). Assuming linear weight gain, SWG was defined as gaining ≥ 10% of baseline weight during follow-up. Proportional hazards models were used to identify significant predictors of SWG separately by EPIC center. Regression coefficients of predictors were pooled using random-effects meta-analysis. Pooled coefficients were used to assign weights to each predictor. The risk score was calculated as a linear combination of the predictors. External validity of the score was evaluated in nine other centers of the EPIC study (validation sample).
resultsOur final model included age, sex, baseline weight, level of education, baseline smoking, sports activity, alcohol use, and intake of six food groups. The model's discriminatory ability measured by the area under a receiver operating characteristic curve was 0.64 (95% CI = 0.63-0.65) in the derivation sample and 0.57 (95% CI = 0.56-0.58) in the validation sample, with variation between centers. Positive and negative predictive values for the optimal cut-off value of ≥ 200 points were 9% and 96%, respectively.
conclusionThe present risk score confidently excluded a large proportion of individuals from being at any appreciable risk to develop SWG within the next 5 years. Future studies, however, may attempt to further refine the positive prediction of the score.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.